| For: | Dung PT, Su HX, Tue NC, Ben NH, Phuong NM, Tran TN, Nghia PB, Van DT, Dung NTT, Vinh HT, Rostaing L, Toan PQ. Predictive value of tacrolimus concentration/dose ratio in first post-transplant week for CYP3A5-polymorphism in kidney-transplant recipients. World J Transplant 2025; 15(2): 103247 [PMID: 40535494 DOI: 10.5500/wjt.v15.i2.103247] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v15/i2/103247.htm |
| Number | Citing Articles |
| 1 |
Anders Larsson, Johan Saldeen, Jonathan Cedernaes, Mats B. Eriksson, Mathias Karlsson, Anna-Karin Hamberg. Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010094
|
| 2 |
Andrea Guzmán-de Antonio, Carlos Jiménez-Martín, Elia B. Márquez-Cabello, Marcos Navares-Gómez, María O. López-Oliva, Elena González-García, Lucía Díaz-García, Rocío Rosas-Alonso, Irene García-García, Alberto M. Borobia, Antonio J. Carcas. Integrating pharmacogenetic and clinical factors to predict the C0/D/W-based tacrolimus phenotype in kidney transplantation. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1772820
|
| 3 |
Manman Liu, Lan Li, Chen Zhou, Changying Luo, Xiaodong Wang, Juan Wu. Case Report: Pediatric isavuconazole supratherapeutic exposure: a case of long-term use, CYP3A5 poor metabolizer genotype and concomitant CYP3A4 medications. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1807350
|